Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Dibaj
S. Dibaj
Janssen Pharmaceutica
Apalutamide
Internal medicine
Medicine
Androgen deprivation therapy
Placebo
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Health-related quality of life (HRQoL) and patient-reported outcomes at final analysis of the TITAN study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).
2021
Journal of Clinical Oncology
Neeraj Agarwal
Simon Chowdhury
Anders Bjartell
Byung Ha Chung
Andrea J. Pereira de Santana Gomes
Robert Given
Álvaro Juárez
Axel S. Merseburger
Mustafa Ozguroglu
Hirotsugu Uemura
Dingwei Ye
Sabine Brookman-May
Suneel Mundle
Sharon Anne McCarthy
Florence Lefresne
S. Dibaj
Katherine B Bevans
Kim N. Chi
Show All
Source
Cite
Save
Citations (0)
Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy.
2021
European urology focus
Stéphane Oudard
Boris Hadaschik
Fred Saad
David Cella
Ethan Basch
Julie N. Graff
Hiroji Uemura
S. Dibaj
Susan Li
Sabine Brookman-May
Peter De Porre
Katherine B Bevans
Jeremiah J. Trudeau
Eric J. Small
Matthew R. Smith
Show All
Source
Cite
Save
Citations (0)
1
map